Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Paraneoplastic rheumatic syndromes.

Csilla András1, Zoltán Csiki, Andrea Ponyi

  • 1Department of Oncology, University of Debrecen, Medical and Health Science Center, 4012, Debrecen, Nagyerdei krt. 98, Hungary.

Rheumatology International
|August 11, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Occurrence of Cold Agglutinin Disease among Patients with Autoimmune Hemolytic Anemia: A Hungarian Single-Center Experience.

Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie·2026
Same author

Circulating CD117+/CD34+/CD45dim Myeloblasts as Biomarkers of Disease Activity in Primary Myelofibrosis-A Pilot Study.

EJHaem·2026
Same author

Pre-Engraftment Syndrome After Autologous Stem Cell Transplantation in Relapsed or Refractory Hodgkin Lymphoma: An Association with Prior PD-1 Inhibitor Exposure.

Medicina (Kaunas, Lithuania)·2026
Same author

Hodgkin Variant Richter's Transformation in the Absence of Classical Risk Factors: A Rare Case With Spinal Manifestation.

Cureus·2026
Same author

Bispecific Antibodies in B-Cell Lymphomas: Mechanisms, Efficacy, Toxicity, and Management.

Medicina (Kaunas, Lithuania)·2026
Same author

The Acute Effects of High-Intensity Interval Training on Oxidative Stress Markers and Phagocyte Oxidative Burst Activity in Young Professional Athletes and Non-Athlete University Students.

Life (Basel, Switzerland)·2026

Paraneoplastic symptoms, not caused by direct tumor invasion, arise from various tumor-derived mediators. Recognizing these syndromes aids early cancer diagnosis and guides treatment response assessment.

Area of Science:

  • Oncology
  • Endocrinology
  • Immunology

Background:

  • Paraneoplastic symptoms are manifestations of malignancy not directly linked to tumor invasion.
  • These symptoms stem from diverse tumor-derived biologic mediators, including hormones, peptides, antibodies, and immune cells.
  • Understanding paraneoplastic syndromes is crucial for comprehensive cancer care.

Purpose of the Study:

  • To highlight the importance of recognizing paraneoplastic syndromes for early cancer detection.
  • To emphasize the role of paraneoplastic symptom severity in monitoring treatment response.
  • To underscore the significance of palliative treatment for improving patient quality of life.

Main Methods:

  • Review of literature on paraneoplastic syndromes and their underlying mechanisms.

Related Experiment Videos

  • Analysis of the relationship between paraneoplastic symptoms and tumor biology.
  • Evaluation of the impact of paraneoplastic symptoms on cancer diagnosis and therapy.

    • Main Results:

    • Paraneoplastic symptoms result from a wide array of tumor-secreted mediators.
    • Early identification of paraneoplastic syndromes can facilitate prompt cancer diagnosis.
    • Clinical assessment of symptom severity correlates with therapeutic effectiveness.

    Conclusions:

    • Paraneoplastic syndromes are critical indicators that can signal the presence of cancer.
    • Monitoring these symptoms offers valuable insights into treatment efficacy.
    • Effective palliative care for paraneoplastic conditions is essential for enhancing patient well-being.